According to the study, which will be presented at the American Academy of Neurology Annual Meeting in April 2026, individuals taking GLP-1 drugs were 10% less likely to visit the ER, 14% less likely to be hospitalised, and around 13% less likely to need procedures like nerve blocks or receive triptan prescriptions than those on topiramate
Wegovy injection costs $1430 monthly irrespective of doses, while Ozempic, used for type 2 diabetes, costs $1029 monthly for the pen injection and 30 once-daily oral tablets (Rybelsus)
The findings from the study were validated in a secondary cohort (Wu et al., 2020b)
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid pentadecapeptide derived from a partial sequence of a protein originally identified in human gastric juice
Dual-action GLP-1/GIP receptor agonists like Zepbound can also mimic the action of GIP, a hormone that helps regulate blood sugar levels and metabolism
Research shows that most adults who stop a GLP-1 medication regain at least some of their weight in the year after stopping the medication, with one study showing an average regain of two-thirds of their previous weight loss